# Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers

> **NCT05091190** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 75 (actual)

## Conditions studied

- Metastatic NSCLC
- Metastatic Head and Neck Cancer

## Interventions

- **OTHER:** Blood draws

## Key facts

- **NCT ID:** NCT05091190
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-27
- **Primary completion:** 2026-12-11
- **Final completion:** 2026-12-11
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091190, "Immunotherapy Clearance and Phenotype of Circulating Tumor Cells in Lung and Head and Neck Cancers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05091190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
